ID   BT-20/CMV-Luc
AC   CVCL_J244
DR   cancercelllines; CVCL_J244
DR   JCRB; JCRB1438
DR   JCRB; NIHS0700
DR   Wikidata; Q54798451
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter.
CC   Sequence variation: Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 8975; PIK3CA; Simple; p.Pro539Arg (c.1616C>G); ClinVar=VCV000376243; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 9884; RB1; Simple; p.Ile388Ser (c.1163T>G); ClinVar=VCV000665312; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 9884; RB1; Simple; p.Pro515Leu (c.1544C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Lys132Gln (c.394A>C); ClinVar=VCV000376628; Zygosity=Homozygous (from parent cell line).
CC   Transfected with: UniProtKB; P08659; Firefly luciferase.
CC   Discontinued: JCRB; NIHS0700; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): JCRB
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11,14
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0178 ! BT-20
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 21
//